annual total liabilities:
$3.55B+$134.72M(+3.95%)Summary
- As of today (August 17, 2025), AMRX annual total liabilities is $3.55 billion, with the most recent change of +$134.72 million (+3.95%) on December 31, 2024.
- During the last 3 years, AMRX annual total liabilities has fallen by -$9.80 million (-0.28%).
- AMRX annual total liabilities is now -2.83% below its all-time high of $3.65 billion, reached on December 31, 2020.
Performance
AMRX Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$3.47B+$44.88M(+1.31%)Summary
- As of today (August 17, 2025), AMRX quarterly total liabilities is $3.47 billion, with the most recent change of +$44.88 million (+1.31%) on June 30, 2025.
- Over the past year, AMRX quarterly total liabilities has dropped by -$44.47 million (-1.27%).
- AMRX quarterly total liabilities is now -12.71% below its all-time high of $3.97 billion, reached on March 31, 2020.
Performance
AMRX quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AMRX Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.0% | -1.3% |
| 3 y3 years | -0.3% | -9.9% |
| 5 y5 years | +6.8% | -5.5% |
AMRX Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +4.0% | -9.9% | +1.7% |
| 5 y | 5-year | -2.8% | +6.8% | -9.9% | +1.7% |
| alltime | all time | -2.8% | >+9999.0% | -12.7% | >+9999.0% |
AMRX Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $3.47B(+1.3%) |
| Mar 2025 | - | $3.42B(-3.4%) |
| Dec 2024 | $3.55B(+3.9%) | $3.55B(+1.5%) |
| Sep 2024 | - | $3.49B(-0.6%) |
| Jun 2024 | - | $3.51B(+1.2%) |
| Mar 2024 | - | $3.47B(+1.8%) |
| Dec 2023 | $3.41B(-5.0%) | $3.41B(-2.4%) |
| Sep 2023 | - | $3.50B(-0.6%) |
| Jun 2023 | - | $3.52B(+1.5%) |
| Mar 2023 | - | $3.46B(-3.5%) |
| Dec 2022 | $3.59B(+1.0%) | $3.59B(-1.8%) |
| Sep 2022 | - | $3.66B(-5.0%) |
| Jun 2022 | - | $3.85B(+11.1%) |
| Mar 2022 | - | $3.47B(-2.5%) |
| Dec 2021 | $3.56B(-2.6%) | $3.56B(-0.6%) |
| Sep 2021 | - | $3.58B(-1.2%) |
| Jun 2021 | - | $3.62B(+1.1%) |
| Mar 2021 | - | $3.58B(-1.9%) |
| Dec 2020 | $3.65B(+9.9%) | $3.65B(-0.8%) |
| Sep 2020 | - | $3.68B(+0.1%) |
| Jun 2020 | - | $3.67B(-7.6%) |
| Mar 2020 | - | $3.97B(+19.8%) |
| Dec 2019 | $3.32B(-4.0%) | $3.32B(+0.3%) |
| Sep 2019 | - | $3.31B(-5.8%) |
| Jun 2019 | - | $3.51B(-2.0%) |
| Mar 2019 | - | $3.58B(+3.7%) |
| Dec 2018 | $3.46B(+101.2%) | $3.46B(-5.7%) |
| Sep 2018 | - | $3.67B(+2.0%) |
| Jun 2018 | - | $3.59B(>+9900.0%) |
| Mar 2018 | - | $0.00(-100.0%) |
| Dec 2017 | $1.72B(+43.2%) | $1.72B(+43.2%) |
| Dec 2016 | $1.20B(+39.4%) | - |
| Dec 2016 | - | $1.20B(-1.4%) |
| Sep 2016 | - | $1.22B(+56.6%) |
| Jun 2016 | - | $776.55M(-4.9%) |
| Mar 2016 | - | $816.87M(-5.0%) |
| Dec 2015 | $860.08M(+347.0%) | $860.08M(-11.1%) |
| Sep 2015 | - | $967.21M(-7.4%) |
| Jun 2015 | - | $1.04B(+17.6%) |
| Mar 2015 | - | $887.94M(+361.5%) |
| Dec 2014 | $192.41M(+1.6%) | $192.41M(-5.5%) |
| Sep 2014 | - | $203.67M(+7.3%) |
| Jun 2014 | - | $189.82M(+20.9%) |
| Mar 2014 | - | $157.02M(-17.1%) |
| Dec 2013 | $189.38M(+9.6%) | $189.38M(-3.4%) |
| Sep 2013 | - | $196.12M(-0.8%) |
| Jun 2013 | - | $197.61M(-6.0%) |
| Mar 2013 | - | $210.32M(+21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $172.87M(-9.4%) | $172.87M(-21.3%) |
| Sep 2012 | - | $219.56M(-28.9%) |
| Jun 2012 | - | $308.95M(+11.5%) |
| Mar 2012 | - | $276.97M(+45.1%) |
| Dec 2011 | $190.85M(-0.7%) | $190.85M(+8.7%) |
| Sep 2011 | - | $175.59M(-6.3%) |
| Jun 2011 | - | $187.40M(+1.4%) |
| Mar 2011 | - | $184.78M(-3.8%) |
| Dec 2010 | $192.18M(-60.0%) | $192.18M(-12.4%) |
| Sep 2010 | - | $219.27M(-50.3%) |
| Jun 2010 | - | $441.02M(-8.7%) |
| Mar 2010 | - | $483.27M(+0.5%) |
| Dec 2009 | $481.02M(+59.0%) | $481.02M(+37.8%) |
| Sep 2009 | - | $349.15M(+1.3%) |
| Jun 2009 | - | $344.74M(-1.3%) |
| Mar 2009 | - | $349.23M(+15.4%) |
| Dec 2008 | $302.58M(-9.5%) | $302.58M(-3.9%) |
| Sep 2008 | - | $314.95M(-3.3%) |
| Jun 2008 | - | $325.62M(-2.6%) |
| Dec 2007 | $334.36M(-3.9%) | $334.36M(-3.9%) |
| Dec 2006 | $347.86M(+38.4%) | $347.86M(+150.0%) |
| Dec 2005 | $251.40M(+277.5%) | - |
| Sep 2004 | - | $139.15M(-5.2%) |
| Jun 2004 | - | $146.78M(+119.0%) |
| Mar 2004 | - | $67.03M(+0.6%) |
| Dec 2003 | $66.60M(+5.1%) | $66.60M(+14.0%) |
| Sep 2003 | - | $58.43M(-13.4%) |
| Jun 2003 | - | $67.47M(-1.8%) |
| Mar 2003 | - | $68.71M(+8.5%) |
| Dec 2002 | $63.34M(+68.2%) | $63.34M(+17.6%) |
| Sep 2002 | - | $53.84M(+7.1%) |
| Jun 2002 | - | $50.27M(+5.0%) |
| Mar 2002 | - | $47.89M(+27.1%) |
| Dec 2001 | $37.66M(+356.4%) | $37.66M(+14.0%) |
| Sep 2001 | - | $33.04M(+6.4%) |
| Jun 2001 | - | $31.04M(+361.3%) |
| Mar 2001 | - | $6.73M(-18.5%) |
| Dec 2000 | $8.25M(-12.5%) | $8.25M(-21.7%) |
| Sep 2000 | - | $10.54M(-8.3%) |
| Jun 2000 | - | $11.49M(+10.1%) |
| Mar 2000 | - | $10.44M(+10.7%) |
| Dec 1999 | $9.43M(+93.3%) | $9.43M(+43.8%) |
| Sep 1999 | - | $6.56M(+18.1%) |
| Jun 1999 | - | $5.55M(-0.1%) |
| Mar 1999 | - | $5.56M(+13.9%) |
| Dec 1998 | $4.88M | $4.88M(+19.3%) |
| Sep 1998 | - | $4.09M(+19.4%) |
| Jun 1998 | - | $3.42M(-5.1%) |
| Mar 1998 | - | $3.61M |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual total liabilities year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual total liabilities?
The current annual total liabilities of AMRX is $3.55B
What is the all time high annual total liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual total liabilities is $3.65B
What is Amneal Pharmaceuticals, Inc. annual total liabilities year-on-year change?
Over the past year, AMRX annual total liabilities has changed by +$134.72M (+3.95%)
What is Amneal Pharmaceuticals, Inc. quarterly total liabilities?
The current quarterly total liabilities of AMRX is $3.47B
What is the all time high quarterly total liabilities for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly total liabilities is $3.97B
What is Amneal Pharmaceuticals, Inc. quarterly total liabilities year-on-year change?
Over the past year, AMRX quarterly total liabilities has changed by -$44.47M (-1.27%)